BetterLife Pharma Inc BETRF

Primary Symbol: C.BETR

Healthcare

BetterLife Pharma Inc. is a biotechnology company. The Company is primarily focused on developing and commercializing two compounds, BETR-001 and BETR-002, to treat neuro-psychiatric and neurological disorders. BETR-001, which is in preclinical and is a non-hallucinogenic and non- controlled lysergic acid diethylamide (LSD) derivative in development and that is unregulated and therefore can be self-administered. Its synthesis patent for BETR-001 eliminates regulatory hurdles and its pending patent, for composition and method of use, covers treatment of major depressive disorder, anxiety disorder and neuropathic pain and other neuro-psychiatric and neurological disorders. BETR-002, which is in preclinical and is based on honokiol, the active anxiolytic ingredient of magnolia bark. Its pending method of use and formulations patent covers treatment of anxiety related disorders including benzodiazepine dependency. It also owns a drug candidate for the treatment of viral infections.

CSE:BETR - Post by User

BetterLife Pharma Inc

<< Previous

Bullboard Posts

Next >>

Post by BBAccount001on Nov 20, 2020 9:48am

792 Views

Post# 31939874

Lastest Press Release

https://finance.yahoo.com/news/pfizer-vaccine-betterlife-pharma-common-123000759.html

These guys are finally starting to pump out some news on a regular. Hopefully the placement closes this week and we also get an update on the trials next week.

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals